Patents by Inventor Shane Atwell

Shane Atwell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20050069975
    Abstract: Methods are provided for increasing yields of soluble protein, including for increasing yields of soluble recombinant protein. Specifically, methods are provided for increasing the solubility and stability of recombinant proteins by co-expression of a phosphatase.
    Type: Application
    Filed: July 9, 2003
    Publication date: March 31, 2005
    Inventors: Shane Atwell, Ingeborg Feil
  • Publication number: 20040253178
    Abstract: The present invention provides machine readable media embedded with the three-dimensional molecular structure coordinates of SYKKD and subsets thereof, including binding pockets, methods of using the structure to identify and design affecters, including inhibitors and activator, mutants of SYKKD, and compounds and compositions that affect SYK activity.
    Type: Application
    Filed: December 17, 2003
    Publication date: December 16, 2004
    Inventors: Shane Atwell, Jorg Hendle, Sean Grant Buchanan, Ingeborg Feil, Marijane Russell, John Badger, Masaki Tomimoto, Michael J. Sauder
  • Publication number: 20040253641
    Abstract: The present invention provides machine readable media embedded with the three-dimensional molecular structure coordinates of EPHA7KD and subsets thereof, including binding pockets, methods of using the structure to identify and design affecters, including inhibitors and activator, mutants of EPHA7KD, EPHA7KD crystals and compounds and compositions that affect EPHA7 activity.
    Type: Application
    Filed: March 5, 2004
    Publication date: December 16, 2004
    Inventors: Shane Atwell, Ian Miller, Ingeborg Feil, John Badger
  • Publication number: 20040248800
    Abstract: The present invention provides machine readable media embedded with the three-dimensional molecular structure coordinates of EGFRKD complexed with AMP-PNP and subsets thereof, including binding pockets, methods of using the structure to identify and design affecters, including inhibitors and activator, mutants of EGFRKD, and compounds and compositions that affect EGFR activity.
    Type: Application
    Filed: March 16, 2004
    Publication date: December 9, 2004
    Inventors: Shane Atwell, Sean Grant Buchanan